PAPER Banfi PI, Volpato E, Nicolini A, Lunetta C, Pagnini F, Esquinas A26581964
PAPER McDermott CJ, Stavroulakis T26581966
PAPER Al-Bustani N, Simonson W, Marshall DA, Vetrovs J, Wener MH, Weiss MD, Wang LH26583492
PAPER Nguyen TP, Biliciler S, Wiszniewski W, Sheikh K26583493
Sibley Memorial Hospital
Linkoping UniversityLinkoping, Sweden
CONFERENCE COVERAGE 2015-11-27 Conference Coverage Despite early disappointments, drug developers have bought into immunotherapy for Alzheimer’s disease, banking on a handful of antibodies and active vaccines currently in Phase 2/3 trials and others in Phase 1. As evident from this ...
CONFERENCE COVERAGE 2015-11-27 Conference Coverage It has become a mantra in the Alzheimer’s field that staying active—physically, cognitively, and socially—can protect the brain against decline. But can this be turned into a viable intervention? At the 8th Clinical Trials in Alzheimer ...
Biologische Heilmittel HeelBaden-Baden, Germany
Johns Creek, United States
PAPER Joyce PI, Fratta P, Landman AS, McGoldrick P, Wackerhage H, Groves M, Busam BS, Galino J, Corrochano S, Beskina OA, Esapa C, Ryder E, Carter S, Stewart M, Codner G, Hilton H, Teboul L, Tucker J, Lionikas A, Estabel J, Ramirez-Solis R, White JK, Brandner S, Plagnol V, Bennet DL, Abramov AY, Greensmith L, Fisher EM, Acevedo-Arozena A26604141
No filters selected